Trials / Not Yet Recruiting
Not Yet RecruitingNCT07123896
Arrhythmia Cohort Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Beijing Anzhen Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Normal treatment with catheter ablation or medicine | Routine clinical care with catheter ablation and/or medicine; real-world clinical cases |
| DRUG | Drug Treatment | Routine clinical care with medicine; real-world clinical cases |
Timeline
- Start date
- 2025-08-24
- Primary completion
- 2030-07-24
- Completion
- 2030-07-24
- First posted
- 2025-08-14
- Last updated
- 2025-08-14
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07123896. Inclusion in this directory is not an endorsement.